UBS Group Raises Cardinal Health (NYSE:CAH) Price Target to $134.00

Cardinal Health (NYSE:CAH - Get Free Report) had its target price lifted by stock analysts at UBS Group from $125.00 to $134.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a "buy" rating on the stock. UBS Group's price objective points to a potential upside of 19.40% from the company's previous close.

CAH has been the topic of a number of other reports. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Cardinal Health from $115.00 to $119.00 and gave the company a "hold" rating in a report on Friday, August 16th. Citigroup dropped their price target on Cardinal Health from $115.00 to $107.00 and set a "neutral" rating for the company in a research note on Friday, July 19th. Evercore ISI lifted their price objective on Cardinal Health from $105.00 to $115.00 and gave the stock an "in-line" rating in a research note on Thursday, August 15th. Robert W. Baird upped their price objective on Cardinal Health from $130.00 to $137.00 and gave the stock an "outperform" rating in a report on Thursday, August 15th. Finally, Morgan Stanley raised their target price on shares of Cardinal Health from $114.00 to $119.00 and gave the company an "overweight" rating in a report on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Cardinal Health presently has an average rating of "Moderate Buy" and a consensus target price of $120.18.

Cardinal Health Stock Down 0.1 %

CAH stock traded down $0.09 during trading on Tuesday, reaching $112.23. The company's stock had a trading volume of 1,102,297 shares, compared to its average volume of 2,078,594. The company's fifty day moving average is $111.23 and its 200-day moving average is $103.92. Cardinal Health has a 1 year low of $90.19 and a 1 year high of $116.05. The company has a market capitalization of $27.34 billion, a P/E ratio of 49.88, a price-to-earnings-growth ratio of 1.57 and a beta of 0.60.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Wednesday, August 14th. The company reported $1.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.10. Cardinal Health had a negative return on equity of 54.85% and a net margin of 0.37%. The company had revenue of $59.87 billion for the quarter, compared to the consensus estimate of $58.74 billion. During the same quarter last year, the company earned $1.55 EPS. The firm's quarterly revenue was up 12.1% on a year-over-year basis. Analysts anticipate that Cardinal Health will post 7.61 earnings per share for the current year.

Insider Activity at Cardinal Health

In other news, insider Jessica L. Mayer sold 17,896 shares of Cardinal Health stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $106.48, for a total transaction of $1,905,566.08. Following the completion of the sale, the insider now directly owns 94,529 shares in the company, valued at approximately $10,065,447.92. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, insider Jessica L. Mayer sold 16,573 shares of the stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $109.39, for a total value of $1,812,920.47. Following the transaction, the insider now owns 75,971 shares of the company's stock, valued at $8,310,467.69. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jessica L. Mayer sold 17,896 shares of Cardinal Health stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $106.48, for a total value of $1,905,566.08. Following the sale, the insider now directly owns 94,529 shares of the company's stock, valued at approximately $10,065,447.92. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 113,963 shares of company stock worth $12,379,980 in the last quarter. 0.15% of the stock is owned by company insiders.

Hedge Funds Weigh In On Cardinal Health

Institutional investors have recently made changes to their positions in the company. Tobam grew its holdings in Cardinal Health by 773.4% during the 1st quarter. Tobam now owns 49,111 shares of the company's stock worth $5,496,000 after acquiring an additional 43,488 shares in the last quarter. Mitsubishi UFJ Trust & Banking Corp increased its holdings in Cardinal Health by 101.1% during the first quarter. Mitsubishi UFJ Trust & Banking Corp now owns 321,558 shares of the company's stock valued at $36,010,000 after buying an additional 161,656 shares during the period. State Board of Administration of Florida Retirement System lifted its holdings in Cardinal Health by 5.2% during the first quarter. State Board of Administration of Florida Retirement System now owns 314,213 shares of the company's stock worth $35,160,000 after buying an additional 15,663 shares during the period. Alpha Cubed Investments LLC bought a new stake in Cardinal Health during the 3rd quarter valued at $371,000. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its holdings in shares of Cardinal Health by 1.7% in the 1st quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 393,350 shares of the company's stock valued at $44,016,000 after acquiring an additional 6,752 shares during the period. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.